BIR Annual Radiotherapy and Oncology meeting 2021 (Part 2)

24th - 26th March 2021   (GMT+01:00) Europe/London

Register for Part 1 of the event and receive 50% off for Part 2. Discount will be added at payment.

Welcome to Part 2 of this inaugural virtual meeting for the BIR, which brings together speakers from around the world and national experts too, to share experiences and expertise in a very wide range of aspects for today’s cutting-edge radiotherapy and oncology. The latest techniques, technologies, methods and issues will be discussed in this comprehensive meeting taking place over two days. Opportunities aplenty for networking with fellow professionals and discussing the latest offerings from manufacturers.

Keynote talks will headline each session, and topic areas will include:

  • Hypofractionation
  • Clinical trials
  • Strategy / Policy/ Workforce 
  • Proffered oral presentations

View event programme here

Who should attend? 
You! If you’re working in radiotherapy and oncology, then this meeting is designed for you – and that is for all disciplines. The BIR is rapidly becoming the home of ALL professionals involved with radiotherapy and oncology and is open to all. So, clinical oncologists, radiographers, physicists, service managers, Linac and IT engineers, dosimetrists, manufacturers, department heads…all are welcome, and there should be something for everyone.

View eLearning materials from the event
Please our excellent line-up of ePosters and YouTube videos presented by an array of fantastic authors.

Sponsor BIRTO 2021

The 'BIR Annual Radiotherapy and Oncology meeting 2021' event offers sponsors an excellent opportunity to reach out to a large number of multidisciplinary medical professionals in a relaxed virtual environment along with an opportunity to choose a speaker of your choice to speak at the event. View our sponsorship brochure - only Silver package available.

To secure sponsorship, please contact


Registration Fees (includes registration for all three days)*

If you attended Part 1 of the event, you are eligible for 50% off for Part 2. Discount will be added at payment.


BIR / IAPM Member Plan 1 £60

BIR Member Plan 2 £50

BIR / IAPM Trainee member £50

BIR / IAPM Retired £40

BIR / IAPM Student member £40

BIR / IAPM Non member £85


*VAT will be added at checkout

Registration information
Payment for all events must be made via a debit or credit card. Invoices and PO numbers cannot be used for registration payment. If you need your hospital, Trust, or organisation to pay for registration fees, we advise them to fill out the event registration form and return to Please note VAT will be added for all virtual events to the registration fees listed. For any further inquiries please contact

If you are having issues registering for the event please create or login to your MyBIR account via this link and then register for the event after you have logged in. If you are still experiencing any issues please email




Advanced Accelerator Applications

Advanced Accelerator Applications, S.A. (AAA), a Novartis company, is an innovative medicines company developing targeted radioligand therapies and precision imaging radioligands for oncology. We are committed to transforming patients’ lives by leading innovation in nuclear medicine. AAA currently has over 1,000 employees working across 31 sites in 12 countries (Canada, France, Germany, Israel, Italy, the Netherlands, Poland, Portugal, Spain, Switzerland, the UK and the US). The company also has global manufacturing capabilities with 19 facilities in eight countries, and six research & development sites. For more information, please visit:


Bayer’s Radiology business is well placed to be the partner of choice in helping NHS trusts to address the many challenges faced today including the increasing need for governance to demonstrate best practice and improving patient care within increasing financial constraints. With market-leading contrast media and power injector systems, Bayer is able to offer innovative patient care and with the addition of its informatics platform, it can support radiology departments in driving protocol standardisation and easily accessible audit data that enable departments to meet further challenges faced around contrast and radiation dose management. 0118 2063999


For almost five decades, Elekta has been a leader in precision radiation medicine. Our more than 4,000 employees worldwide are committed to ensuring everyone in the world with cancer has access to – and benefits from – more precise, personalized radiotherapy treatments. Headquartered in Stockholm, Sweden, Elekta is listed on NASDAQ Stockholm Exchange. Visit or follow @Elekta on Twitter. A pioneer in precision radiation medicine, Elekta develops and supports a range of advanced linear accelerators (linacs) that enable physicians to deliver precise, rapid and patient-specific radiotherapy for individuals with cancer. Elekta's line of high definition digital accelerators includes the latest generation Versa HD™ – a system designed to treat a spectrum of tumours throughout the body using both conventional and highly sophisticated techniques – as well as the clinically-proven and widely used Elekta Synergy® and Elekta Infinity™ linacs. MOSAIQ® Plaza is a comprehensive suite of digital tools that works seamlessly with Elekta radiotherapy systems to provide the foundation for intelligence-driven, value-based healthcare. MOSAIQ Plaza's smart data centre connects healthcare professionals to patients through every step of their journey to ensure efficient, standardized daily practice. Bringing people and information together, MOSAIQ Plaza allows departments to continuously improve their processes, reduce costs and touch more patients' lives.

GE Healthcare Ltd

GE Healthcare is a leading provider of medical imaging, monitoring, and life science technologies. GE Healthcare enables precision health in diagnostics, therapeutics and monitoring through intelligent devices, data analytics, applications and services to help providers, researchers and life sciences companies in their mission to improve outcomes for patients around the world.

MVision AI

MVision AI is a pioneering SaaS provider for radiotherapy treatment planning. Our AI-powered segmentation tool helps to standardize and automate contouring, including lymph nodes, to streamline workflow in radiotherapy. Our deep learning model produces consistent contouring in minutes while maintaining the highest standards of quality for every patient, every time.

Philips Healthcare

Enabling better health and better care at lower cost Philips is a leading health technology company focused on improving people`s lives across the health continuum - from healthy living and prevention, to diagnosis, treatment and home care. Applying advanced technologies and deep clinical and consumer insights, Philips delivers integrated solutions that improve people`s health and enable better outcomes. Partnering with its customers, Philips seeks to transform how healthcare is delivered and experienced. The company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care.


PTW designs, develops, manufactures and distributes high quality dosimetry and quality control equipment mainly for use in the medical field, especially in radiation therapy, diagnostic radiology and nuclear medicine. We have a global network of subsidiaries including here in the UK and ROI. Our products are well known throughout the world and are recognized for their workmanship and high level of quality.

RaySearch UK Limited

ADVANCING CANCER TREATMENT RaySearch is a committed pioneer of oncology software. Since 2000, we have worked in close cooperation with leading cancer centers to improve life and outcomes for patients. We develop all our products from the ground up and continuously revise every aspect, from algorithms to user interface designs. Medical science never stands still, and neither does RaySearch—our relentless drive to do things better leads us to ever-higher performance, accuracy, safety and usability. And this is just the beginning. We believe software is the driving force for innovation in oncology today. Our systems use groundbreaking automation and machine learning to create new possibilities. RayCare®*, the next-generation oncology information system, will enable one workflow for all the oncology disciplines, ensuring fluid coordination of tasks and optimal use of resources. RayStation® harmonizes treatment planning, providing one point of control for all planning needs—any equipment, any scale. * Subject to regulatory clearance in some markets.

Rosemont Pharma

At Rosemont our mission is to improve the health, quality of life and wellbeing of vulnerable patients through the development, manufacture and supply of high-quality prescription oral liquid medicines. Our ambition has always been to support both patients with swallowing difficulties and the healthcare professionals who care for them.

Siemens Healthineers

Siemens Healthineers is shaping the future of Healthcare. As a leading medical technology company headquartered in Erlangen, Germany, Siemens Healthineers enables healthcare providers worldwide through its regional companies to increase value by empowering them on their journey towards expanding precision medicine, transforming care delivery, improving the patient experience, and digitalising healthcare. Siemens Healthineers is continuously developing its product and service portfolio, with AI-supported applications and digital offerings that play an increasingly important role in the next generation of medical technology. These new applications will enhance the company’s foundation in in-vitro diagnostics, image-guided therapy, and in-vivo diagnostics. Siemens Healthineers also provides a range of services and solutions to enhance healthcare providers’ ability to provide high-quality, efficient care to patients. For more information and latest product line visit

Sun Nuclear Corporation

Sun Nuclear provides innovative solutions for Radiation Therapy, Diagnostic Imaging and Patient Alignment. Our mission is to enable healthier lives by improving the detection and treatment of cancer. More than 5,000 cancer centers worldwide rely on us for independent, integrated Quality Management. With a focus on ongoing support, we aim to ease technology adoption, enhance workflows and improve outcomes – so that healthcare providers can achieve real results for Patient Safety.

Terumo Interventional Systems

At Terumo Interventional Systems, we constantly work to refine and perfect our products so that physicians can do more. Our QuiremSpheres (Selective Internal Radiation) Holmium Platform delivers a first in SIRT: a comprehensive end-to-end platform for treating unresectable liver tumours.

Varian Medical Systems UK Ltd


Xiel is a specialist distributor of medical technologies in the UK and Ireland. We work with global leading solution providers including Sun Nuclear Corporation, CIRS Inc, CIVCO, Cablon Medical, Adaptiiv, Eckert and Ziegler and Rotop, to continuously improve efficiency and quality for all our customers.